Men and women were excluded from the study if they:
• Had worsening of asthma that required a change in the dose of ICS and
LABA within six weeks before starting the study.
• Had chronic obstructive pulmonary disease or any other lung disease.
• Were current smokers or former smokers with a history of smoking at
least 20 cigarettes daily for 10 years.
• Had any medical condition that the study doctor thought would affect
the results of the study.
•
A total of 2436 patients received at least one dose of the study medicines. The table
below shows the gender and age of these patients.
Patients who received at least one dose of the study medicines
Group 1 Group 2 Group 3 Group 4 Group 5 Group 6
Treatment
Groups 407 405 406 406 404 408
patients patients patients patients patients patients
254 262 248 252 240 258
Female
(62%) (65%) (61%) (62%) (59%) (63%)
153 143 158 154 164 150
Male
(38%) (35%) (39%) (38%) (41%) (37%)
Age Range
19 to 85 18 to 88 18 to 80 20 to 84 18 to 82 18 to 78
(years)
Average Age
53 52 53 54 54 54
(years)
For more detailed information about the patients included in this study, see the
scientific results summaries (links to those summaries are provided at the end of this
document).